^
Association details:
Biomarker:Chr t(9;11)
Cancer:Chronic Myeloid Leukemia
Drug Class:Tyrosine kinase inhibitor
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Source:
Title:

Overlapping B-Cell Non-Hodgkin Lymphoma with Myeloid Malignancies: A Case Series

Published date:
09/01/2021
Excerpt:
A 58-year old male who was diagnosed with chronic myeloid leukemia and showed accelerated profile….His cytogenetics showed t(9,11) and extra Philadelphia chromosome. This patient received high-dose cytarabine with tyrosine kinase inhibitors and showed good response.
Secondary therapy:
cytarabine